N3C Domain Team: Pharmacoepidemiology

Mission

Mission

The Pharmacoepidemiology Clinical Domain Team aims to help design the best scenarios for drugs already in use and to provide support for the best possible trials. The overall goal is to evaluate important, empirically testable hypotheses regarding the use, safety, and effectiveness of therapies for treating COVID-19 using a limited dataset from the N3C Data Enclave. These data will provide urgently needed information for deploying therapeutic agents to treat patients with COVID-19 infection.

Team meetings are held every other Monday at 4:00pm ET. Please email n3c-tt-pharmacoepidemiology@googlegroups.com to be added to the calendar invite.


Join the Team!

First Time Users: To get started with N3C and gain access to the N3C Data Enclave, please view the Researcher Essentials webpage.
For Questions or Comments: Please access the N3C Support Desk and click on "Request Domain Team Support".
Google Drive:
Pharmacoepidemiology Drive
Google Group:
n3c-tt-pharmacoepidemiology@googlegroups.com
Slack Channel:
Join the Conversation

Leadership

Caleb Alexander, MD
Johns Hopkins Medicine
Hemalkumar Mehta, PhD
Johns Hopkins Bloomberg School of Public Health

To Cite the N3C: "The analyses described in this [publication/report/presentation] were conducted with data or tools accessed through the NCATS N3C Data Enclave https://covid.clinicalcohort.org and N3C Attribution & Publication Policy v 1.2-2020-08-25b supported by NCATS Contract No. 75N95023D00001 and [insert additional funding agencies or sources and reference numbers as declared by the contributors in their form response above]. This research was possible because of the patients whose information is included within the data and the organizations (https://ncats.nih.gov/n3c/resources/data-contribution/data-transfer-agreement-signatories) and scientists who have contributed to the on-going development of this community resource [https://doi.org/10.1093/jamia/ocaa196]."

For publication submission information, please see the Publication Review Page

Sign up for the N3Connect Bulletin.